Search clinical trials for: MCC-257

Total 3842 results

1
2
3
4
5
6
7
8
9
10
...
76
77
›

Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy

Diabetic Polyneuropathy
Yale University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Impact of Family-Centered Care for Intimate Partner Violence (IPV)

Intimate Partner Violence

United States
MC2 Therapeutics

Completed

The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial (ITCHINESS)

Chronic Kidney Disease-associated Pruritus

United Kingdom
Maastricht University Medical Center

Recruiting

Determination of the Optimal Nutrient Mix to Acutely Increase Plasma Ketones

Overweight and Obesity

Netherlands
MC2 Therapeutics

Completed

Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) (Orchid 1)

Vulvar Lichen Sclerosus

Denmark
DBV Technologies

Completed

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children (OLFUS-VIPES)

Peanut Allergy

United States, Netherlands, France, Canada
Crucell Holland BV
National Institute of Allergy and Infectious Diseases (NIAID); Beth Israel...

Completed

Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers

Healthy

United States
DBV Technologies

Completed

Safety Study of Viaskin Peanut to Treat Peanut Allergy (REALISE)

Peanut Allergy

United States, Canada
BiondVax Pharmaceuticals ltd.

Completed

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)

Healthy

Israel
GlaxoSmithKline

Completed

Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study.

Pulmonary Disease, Chronic Obstructive

China
DBV Technologies

Completed

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy (VIPES)

Peanut Allergy

United States, Netherlands, France, Canada, Poland
DBV Technologies
Todd D. Green MD, DBV Technologies

Available

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Peanut Allergy

United States
GlaxoSmithKline

Completed

A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Ukraine, Slovakia
GlaxoSmithKline

Completed

Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg

Pulmonary Disease, Chronic Obstructive

Germany, Estonia
DBV Technologies

Active, not recruiting

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children (EPOPEX)

Peanut Allergy

United States
GlaxoSmithKline

Completed

A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients

Pulmonary Disease, Chronic Obstructive

United Kingdom
DBV Technologies

Completed

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age (EPITOPE)

Peanut Allergy

United States, Canada, Australia, France, Germany, United Kingdom, Ireland, Netherlands
Alexza Pharmaceuticals, Inc.

Completed

Staccato Fentanyl Single and Multidose PK

Breakthrough Pain

United States
Tel-Aviv Sourasky Medical Center
Amorphical Ltd.

Unknown

Amorphous Calcium Carbonate (Acc) Versus Crystalline Calcium Carbonate (Ccc) Using Stable Calcium Isotopes In Postmenopausal Women

Postmenopause

Israel
GlaxoSmithKline

Completed

Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses

Pulmonary Disease, Chronic Obstructive

United States
Klinikum Bayreuth GmbH

Completed

Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling

Influenza

Germany
Hawaii Pacific Health

Recruiting

Tension Versus no Tension With Foley Bulb Induction

Induction of Labor Affected Fetus / Newborn

United States
University of Minnesota

Completed

Mobile Food Record on Recall Effects

Healthy

United States
Mitsubishi Tanabe Pharma Corporation

Completed

MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients

Myocardial Infarction

United States
GlaxoSmithKline

Completed

A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)

Asthma

Netherlands
Takeda

Completed

Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

Congestive Heart Failure

United States
AnX Robotica Corp.

Completed

Comparative Study of MCCE With/Without Tether vs Conventional Upper Endoscopy in Patients With Upper Abdominal Symptoms

Upper Gastrointestinal Symptoms

United States
Sunovion Respiratory Development Inc.

Completed

A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (GOLDEN-2)

COPD

United States
GlaxoSmithKline

Completed

A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Russian Federation, Chile, South Africa, Romania, Mexico, Norway
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Terminated

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

United States
Mylan Pharmaceuticals Inc

Terminated

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

Healthy

United States
RAND
National Institute of Mental Health (NIMH); University of California, Los Angeles

Unknown

My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness (MCC)

Schizophrenia | Bipolar Disorder | Major Depression | Chronic Mental Illness

United States
Vedic Lifesciences Pvt. Ltd.

Recruiting

A Study for Assessing the Efficacy and Safety ParActin® in Individuals With Upper Respiratory Tract Infections

Upper Respiratory Tract Infections

India
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

Healthy

United States
DBV Technologies
University Hospital, Geneva

Completed

Viaskin Pertussis Vaccine Trial

Whooping Cough

Switzerland
Emirates Health Services (EHS)
University of Sharjah

Completed

Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism

L-thyroxine

United Arab Emirates
Nigde Omer Halisdemir University

Completed

Use of Intrathecal Analgesia in Appendectomy

Analgesia | Anesthesia
Tel-Aviv Sourasky Medical Center

Unknown

Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles

In-vitro Fertilization
Quadram Institute Bioscience
Norfolk and Norwich University Hospitals NHS Foundation Trust

Completed

Effect of Phytin on Human Gut Microbiome (EPoM) (EPoM)

Diet Modification

United Kingdom
GlaxoSmithKline

Completed

Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)

Asthma

United States, Canada
First Affiliated Hospital of Fujian Medical University

Completed

Study of 18F-Thretide PET/CT in Patients With Prostate Cancer

Prostate Cancer

China
DSM Nutritional Products, Inc.
Leatherhead Food Research

Completed

Pharmacokinetics of Calcifediol and Cholecalciferol

Osteoporosis
Brightseed

Recruiting

Dietary Supplementation on Gastrointestinal Barrier Function

Intestinal Permeability

United States
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Technology Enhanced Family Treatment

Mood Disorders | Bipolar Disorder | Major Depression

United States
Tri-Service General Hospital

Completed

Comparison of Difference Hydrodissection for CTS

Carpal Tunnel Syndrome

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics of Ascending Single IV Doses of ERB-257

Healthy Subjects

United States
Pascual Gregori Roig
Hospital Universitario de la Plana; FUNDACIÓN DAVALOS FLETCHER

Completed

Influence of Umbilical Cord Clamping Time in the Newborn

Hyperbilirubinemia, Neonatal | Anemia Neonatal | Polycythemia Secondary

Spain
AbbVie

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics (PK) of Ascending Single IV Doses of ERB-257 in Healthy Japanese Males

Healthy Subjects

Japan
Vedic Lifesciences Pvt. Ltd.

Completed

Efficacy and Tolerability of Rehmannia Glutinosa Leaf Extract in the Treatment of Acne Vulgaris

Acne Vulgaris

India

1
2
3
4
5
6
7
8
9
10
...
76
77
›

3

Subscribe